Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization

Blood

Volumn 91, Issue 8, 1998, Pages 3007-3010

  Cigudosa, Juan C ^b   Rao, Pulivarthi H ^b   Calasanz, M Jose ^b   Odero, M Dolores ^b   Michaeli, Joseph ^b   Jhanwar, Suresh C ^b   Chaganti, R S K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CHROMOSOME LOSS; CLINICAL ARTICLE; CYTOGENETICS; DNA HYBRIDIZATION; FEMALE; GENOME; HUMAN; MALE; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032522947     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.8.3007.3007_3007_3010     Document Type: Article

References (20)

1. Mitelman F: Catalog of Chromosome Aberrations in Cancer (ed 5). New York, NY, Wiley-Liss, 1994
2. Sawyer JR, Waldrom JA, Jagannath S, Barlogie B: Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 82:41, 1995
3. Ankathil R, Madhavan J, Gangadharan VP, Pillai GR, Nair MK: Nonrandom karyotype abnormalities in 36 multiple myeloma patients. Cancer Genet Cytogenet 83:71, 1995
4. Smadja NV, Louvet C, Isnard F, Dutel J-L, Grange M-J, Varette C, Krulik M: Cytogenetic study in multiple myeloma at diagnosis: Comparison of two techniques. Br J Haematol 90:619, 1995
5. Lai JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk KV, Flactif M, Morel P, Jouet JP, Bauters F, Facon T: Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490, 1995
6. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Sole F, Cuesta B, Gullon A: Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations. Genes Chromosom Cancer 18:84, 1997
7. Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH, Naucke S, Sawyer JR: Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 86:4250, 1995
8. Calasanz MJ, Cigudosa JC, Odero MD, Garcia-Foncillas J, Marin J, Ardanaz MT, Rocha E, Gullon A: Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with mulitple myeloma. Br J Haematol 98:418, 1997
9. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818, 1992
10. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10:231, 1994
11. Houldsworth J, Chaganti RSK: Comparative genomic hibridization: An overview. Am J Pathol 145:1253, 1994
12. Cigudosa JC, Calsanz MJ, Odero MD, Prosper F, Etxaniz A, Marin J, Rifon J, Gullon A, Rocha E: Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other clinical parameters. Cancer Genet Cytogenet 78:210, 1994
13. Feinman R, Sawyer J, Hardin J, Tricot G: Cytogenetics and molecular genetics in multiple myeloma. Hematol Oncol Clin North Am 11:1, 1997
14. Drach J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, Rothermundt C, Gsur A, Jäger U, Heinz R, Lechner K, Ludwig H, Huber H: Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hibridization. Cancer Res 55:3854, 1995
15. Drach J, Angerler J, Schuster J, Rothermundt C, Thalhammer R, Haas OA, Jager U, Fiegl M, Geissler K, Ludwing H, Huber H: Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 86:3915, 1995
16. Bullrich F, Veronese ML, Kitada S, Jurlander J, Caligiuri MA, Reed JC, Croce CM: Minimal region loss at 13q14 in B-cell chronic lymphocytic leukemia. Blood 88:3109, 1996
17. Liu Y, Hermanson M, Grander D, Merup M, Wu X, Heyman M, Rasool O, Juliusson G, Gahrton G, Detlofsson R, Nikiforova N, Buys C, Söderhäll S, Yankovsky N, Zabarovsky E, Einhorn S: 13q deletions in lymphoid malignancies. Blood 86:1911, 1995
18. Avet-Loiseau H, Andree-Ashley LE, Moore II D, Mellerin MP, Feusner J, Bataille R, Pallavicini MG: Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes Chromosom Cancer 19:124, 1997
19. Offit K, Parsa NZ, Gaidano G, Filippa DA, Louie D, Pan D, Jhanwar SC, Dalla-Favera R, Chaganti RSK: 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 82:2157, 1993
20. Gaidano G, Hauptschein RS, Parsa NZ, Offit K, Rao PH, Lenoir G, Knowles DM, Chaganti RSK, Dalla-Favera R: Deletions involving two distinct regions of 6q in B-cell non-Hodgkin's lymphoma. Blood 80:1781, 1992